High Classification Accuracy for Schizophrenia with Rest and Task fMRI Data

Department of CSEE, University of Maryland Baltimore County, MD, USA.
Frontiers in Human Neuroscience (Impact Factor: 3.63). 06/2012; 6:145. DOI: 10.3389/fnhum.2012.00145
Source: PubMed


We present a novel method to extract classification features from functional magnetic resonance imaging (fMRI) data collected at rest or during the performance of a task. By combining a two-level feature identification scheme with kernel principal component analysis (KPCA) and Fisher's linear discriminant analysis (FLD), we achieve high classification rates in discriminating healthy controls from patients with schizophrenia. Experimental results using leave-one-out cross-validation show that features extracted from the default mode network (DMN) lead to a classification accuracy of over 90% in both data sets. Moreover, using a majority vote method that uses multiple features, we achieve a classification accuracy of 98% in auditory oddball (AOD) task and 93% in rest data. Several components, including DMN, temporal, and medial visual regions, are consistently present in the set of features that yield high classification accuracy. The features we have extracted thus show promise to be used as biomarkers for schizophrenia. Results also suggest that there may be different advantages to using resting fMRI data or task fMRI data.

Download full-text


Available from: Tom Eichele,
68 Reads
  • Source
    • "Whitfield-Gabrielli et al. (Whitfield-Gabrieli et al., 2009) analyzed DMN using both restingstate and working-memory task fMRI for SZ, relatives of SZ patients, and HC, suggesting that SZ patients and their relatives exhibited significantly reduced task-related suppression in medial prefrontal cortex. In addition, others have shown fMRI network connectivity (Arbabshirani et al., 2013) or network maps (Du et al., 2012a; Fan et al., 2011) extracted via ICA provided promising disease markers for diagnosing SZ. However, most of previous studies merged SAD patients with SZ or BP patients probably due to the relatively low reliability of SAD (Maj et al., 2000). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia (SZ), bipolar disorder (BP) and schizoaffective disorder (SAD) share some common symptoms, and there is a debate about whether SAD is an independent category. To the best of our knowledge, no study has been done to differentiate these three disorders or to investigate the distinction of SAD as an independent category using fMRI data. The present study is aimed to explore biomarkers from resting-state fMRI networks for differentiating these disorders and investigate the relationship among these disorders based on fMRI networks with an emphasis on SAD. Firstly, a novel group ICA method, group information guided independent component analysis (GIG-ICA), was applied to extract subject-specific brain networks from fMRI data of 20 healthy controls (HC), 20 SZ patients, 20 BP patients, 20 patients suffering SAD with manic episodes (SADM), and 13 patients suffering SAD with depressive episodes exclusively (SADD). Then, five-level one-way analysis of covariance and multiclass support vector machine recursive feature elimination were employed to identify discriminative regions from the networks. Subsequently, the t-distributed stochastic neighbor embedding (t-SNE) projection and the hierarchical clustering methods were implemented to investigate the relationship among those groups. Finally, to evaluate the generalization ability, 16 new subjects were classified based on the found regions and the trained model using original 93 subjects. Results show that the discriminative regions mainly include frontal, parietal, precuneus, cingulate, supplementary motor, cerebellar, insula and supramarginal cortices, which performed well in distinguishing different groups. SADM and SADD were the most similar to each other, although SADD had greater similarity to SZ compared to other groups, which indicates SAD may be an independent category. BP was closer to HC compared with other psychotic disorders. In summary, resting-state fMRI brain networks extracted via GIG-ICA provide a promising potential to differentiate SZ, BP, and SAD. Copyright © 2015. Published by Elsevier Inc.
    NeuroImage 07/2015; 122. DOI:10.1016/j.neuroimage.2015.07.054 · 6.36 Impact Factor
  • Source
    • "The main target of these studies has been the Alzheimer's disease (Li et al., 2002; Greicius et al., 2004; Wang et al., 2006; Supekar et al., 2008). However, rfMRI data have been rarely used for discrimination of schizophrenia (Cecchi et al., 2009; Shen et al., 2010; Du et al., 2012). Shen et al. (2010) used an atlas-based method to extract mean time-courses of 116 brain regions in the resting-state for both healthy controls and schizophrenia subjects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a growing interest in automatic classification of mental disorders based on neuroimaging data. Small training data sets (subjects) and very large amount of high dimensional data make it a challenging task to design robust and accurate classifiers for heterogeneous disorders such as schizophrenia. Most previous studies considered structural MRI, diffusion tensor imaging and task-based fMRI for this purpose. However, resting-state data has been rarely used in discrimination of schizophrenia patients from healthy controls. Resting data are of great interest, since they are relatively easy to collect, and not confounded by behavioral performance on a task. Several linear and non-linear classification methods were trained using a training dataset and evaluate with a separate testing dataset. Results show that classification with high accuracy is achievable using simple non-linear discriminative methods such as k-nearest neighbors (KNNs) which is very promising. We compare and report detailed results of each classifier as well as statistical analysis and evaluation of each single feature. To our knowledge our effects represent the first use of resting-state functional network connectivity (FNC) features to classify schizophrenia.
    Frontiers in Neuroscience 07/2013; 7(7):133. DOI:10.3389/fnins.2013.00133 · 3.66 Impact Factor
  • Source
    • "There is a remarkable disparity between the performance estimates reported in the literature and clinical utility, some of which lead to strikingly different conclusions about the relative quality of modeling approaches. For example, the performance (prediction accuracy , sensitivity, specificity) of the modeling approach employed by Tang et al. (2012) (93%, 86%, 100%, respectively), and Du et al. (2012) (93%, 93%, 93%) are very similar. The two methods would be tied if the J-statistic (J = SS + SP − 1) (Youden, 1950) were used to compare them, but PPV gives a drastically different picture (100% vs. 27.4% for Tang et al. and Du et al., respectively). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Central to the development of clinical applications of functional connectomics for neurology and psychiatry is the discovery and validation of biomarkers. Resting state fMRI (R-fMRI) is emerging as a mainstream approach for imaging-based biomarker identification, detecting variations in the functional connectome that can be attributed to clinical variables (e.g., diagnostic status). Despite growing enthusiasm, many challenges remain. Here, we assess evidence of the readiness of R-fMRI based functional connectomics to lead to clinically meaningful biomarker identification through the lens of the criteria used to evaluate clinical tests (i.e., validity, reliability, sensitivity, specificity, and applicability). We focus on current R-fMRI-based prediction efforts, and survey R-fMRI used for neurosurgical planning. We identify gaps and needs for R-fMRI-based biomarker identification, highlighting the potential of emerging conceptual, analytical and cultural innovations (e.g., the Research Domain Criteria Project (RDoC), open science initiatives, and Big Data) to address them. Additionally, we note the need to expand future efforts beyond identification of biomarkers for disease status alone to include clinical variables related to risk, expected treatment response and prognosis.
    NeuroImage 04/2013; 80. DOI:10.1016/j.neuroimage.2013.04.083 · 6.36 Impact Factor
Show more